Nika Pharmaceuticals Net Debt Growth & History (NIKA)
Nika Pharmaceuticals's net debt was $316,735 for fiscal 2025.
View full Nika Pharmaceuticals company overviewNika Pharmaceuticals annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $316,735 | $79,654 | +33.60% |
| 2024 | 2024-12-31 | $237,081 | $154,932 | +188.60% |
| 2023 | 2023-12-31 | $82,149 | $64,833 | +374.41% |
| 2022 | 2022-12-31 | $17,316 | −$6,303 | −26.69% |
| 2021 | 2021-12-31 | $23,619 | — | — |
Nika Pharmaceuticals quarterly net debt
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $337,692 | $69,144 | +25.75% |
| Q1 2026 | 2026-03-31 | $330,094 | $80,067 | +32.02% |
| Q4 2025 | 2025-12-31 | $316,735 | $79,654 | +33.60% |
| Q3 2025 | 2025-09-30 | $277,877 | $69,099 | +33.10% |
| Q2 2025 | 2025-06-30 | $268,548 | −$356,263 | −57.02% |
| Q1 2025 | 2025-03-31 | $250,027 | $17,871 | +7.70% |
| Q4 2024 | 2024-12-31 | $237,081 | $154,932 | +188.60% |
| Q3 2024 | 2024-09-30 | $208,778 | $133,943 | +178.98% |
| Q2 2024 | 2024-06-30 | $624,811 | — | — |
| Q1 2024 | 2024-03-31 | $232,156 | $195,270 | +529.39% |
| Q4 2023 | 2023-12-31 | $82,149 | $64,833 | +374.41% |
| Q3 2023 | 2023-09-30 | $74,835 | — | — |
| Q1 2023 | 2023-03-31 | $36,886 | — | — |
| Q4 2022 | 2022-12-31 | $17,316 | — | — |
Nika Pharmaceuticals net debt trends
Between the periods ended 2021-12-31 and 2025-12-31, Nika Pharmaceuticals's net debt increased from $23,619 to $316,735, a change of $293,116. The latest reported quarter, Q2 2026, shows $337,692.
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Nika Pharmaceuticals source filings ↗